Biogen Idec
-
Merck & Co., Inc. Management Presents at UBS Global Healthcare Conference (Transcript)
… and he's been there for just six or seven years now. And before that you probably remember him when he was CFO of Biogen Idec . But Peter's going to make a presentation and then we may have a little bit of time for a question or two in here …
-
Here's Why Amgen Shares Are Worth $117 To $126 Today
… instance, this year so far shares of Gilead Sciences ( GILD ) (up 50% YTD), Celgene ( CELG ) (up 57% YTD), Biogen Idec ( BIIB ) (up 55% YTD), and Regeneron Pharmaceuticals ( REGN ) (up 55% YTD) have all increased between 50 and 57 …
-
New Morningstar Analyst Report for Baxter International Inc.
Biogen Idec and Novo Nordisk are taking aim at Baxter ..... competition for Advate from the likes of Biogen - Idec and Novo Nordisk over the next few years ..... competitors in the field for years, Biogen - Idec plans to launch a long-acting recombinant …
-
New Morningstar Analyst Report for Biogen Idec Inc
… agreements between Biogen and partner Roche ..... collaboration with Roche. Biogen Idec markets novel MS ..... market share from Biogen 's products ..... reach the market. Biogen Idec enjoys steady profitability ..... addition, Roche and Biogen Idec brought ocrelizumab …
-
These Growth Funds Aren't Laggards… they don't blow investors up. But this fund is quite aggressive. It has a 10% position in its top name, which is Biogen Idec , and most of the assets are really stuffed into the top holdings. Courage of your convictions is a cliche, but in …
aggressive. It has a 10% position in its top name, which is Biogen Idec , and most of the assets are really stuffed into the top holdings. Courage of your convictions is a cliche, but in this -
Cramer's Lightning Round - Selling SunTrust Was A Mistake (5/9/13)
… others. It has a good yield." Arm Holdings ( ARMH ): "It just went up 10 points. Let it come down and then buy it." Biogen ( BIIB ): "This is coming back. It is going to go to $200. At that point, people will say it is a head and shoulders pattern …
-
New Morningstar Analyst Report for Merck
… veteran Judy Lewent, who announced her retirement in early 2007. Kellogg's resume also includes the CFO role at Biogen Idec . Merck's board is packed with current and retired CEOs, which can lead to quid pro quo compensation packages for …
-
3 Bio Companies Facing The Patent Cliff
… biotech companies facing significant revenue loss in 2013 due to patent expiration - Eli Lilly & Co ( LLY ), Biogen Idec Inc . ( BIIB ) and Johnson & Johnson ( JNJ ). The patent cliff threat Between now and 2018, the world's largest companies …
-
Biogen Idec - Too High Too Fast?
By William Meyers : Biogen Idec ( BIIB ) is now off its 52-week high of $226.18 (reached earlier ..... timing could have picked up shares at $40.27 on Nov. 28, 2008. Biogen then rose to $67.05 by the end of 2010, and looks like it invented …
-
Cramer's Mad Money - Why Analysts Were Wrong About Microsoft (4/25/13)
… it is time to look at the company in a different light. Stocks for 2020: Gilead ( GILD ), Celgene ( CELG ), Biogen IDEC ( BIIB ), Google ( GOOG ), Facebook ( FB ), Netflix ( NFLX ), Conoco-Phillips ( COP ), Enbridge ( ENB ), Facebook …